Article
Alcohol induces sorafenib resistance in hepatocellular carcinoma: A Translational Study
2025-07-01
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Alcohol is a major cause of hepatocellular carcinoma (HCC), accounting for 30% of cases worldwide. Sorafenib, a tyrosine kinase inhibitor (TKI), was the standard first-line treatment for advanced HCC until 2021, but sorafenib resistance is common. We explored the impact of chronic alcohol exposure (CAE) on sorafenib response and sought to identify associated...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bcd67af0-f15e-5f16-83f7-d9c8b165004f
- DOI
- 10.21203/rs.3.rs-6837338/v1
